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Acute respiratory distress syndrome (ARDS) is difficult to treat and has a 
mortality rate of 40-60%.  During ARDS, cytokine levels in the lungs are elevated and 
patients are treated with hyperoxia and mechanical ventilation.  Alone, these three factors 
can cause lung injury but the combination is thought to worsen lung damage.  Using an 
over-distension model of lung injury, I investigated the effect of excessive mechanical 
stretch on a monolayer of murine alveolar epithelial cells (MLE-12) treated with the pro-
inflammatory cytokine tumor necrosis factor-alpha (TNF-α).  Results show that 
monolayer damage, i.e. formation of cell-free areas, may begin as early as 30 minutes 
from the beginning of excessive stretch. Moreover, the cell-free area formation due to 
TNF-α and stretch together was 16% greater than the cell-free area formed due to either 
stimulus alone. Future studies are needed to elucidate the cause of this form of damage.  
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Chapter I: Introduction 
 
 
Acute respiratory distress syndrome (ARDS) is a severe form of lung dysfunction 
that annually affects over 150,000 Americans and 2.2 million people worldwide (ARDS 
Foundation, 2014).  ARDS has many causes but pneumonia and sepsis contribute to the 
majority cases (Matthay, Ware, & Zimmerman, The acute respiratory distress syndrome, 
2012).  In addition, ARDS can develop from various traumatic insults to the lungs such 
as near drowning and gastric acid aspiration (ARDS Foundation, 2014).  Some common 
characteristics of ARDS are reduced oxygenation of the blood (hypoxemia), fluid in the 
alveolar spaces of the lungs (edema), and reduced lung compliance (Sharma, 2010).  The 
mortality rate of ARDS patients ranges from 40-60% (ARDS Network, 2000) and 
patients typically die from sepsis, multi-organ failure, or irreversible respiratory failure 
(Sharma, 2010). 
 The hypoxemia in ARDS patients is treated with supplemental oxygen 
(hyperoxia) and if the hypoxemia persists, the patient is treated with mechanical 
ventilation (MV).  Positive pressure MV forces air into the lungs to assist or replace a 
patient’s spontaneous breathing. In some cases, large volumes of air are required to 
oxygenate the blood of ARDS patients.  When large volumes of air are used to ventilate 
the lungs, alveoli can be over-distended which leads to more lung injury (Plataki & 
Hubmayr, 2010).  When this occurs, it is known as ventilator-associated lung injury 
(VALI).  The only proven methods for reducing VALI are MV with low tidal volumes 
and careful administration of positive end-expiratory pressure (PEEP).   
 In addition to VALI, supplemental oxygen (hyperoxia) is also known to 
negatively affect the alveoli by increasing lung injury and apoptosis in epithelial cells 
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(Makena et al., 2010). Furthermore, the combination of the two treatments—hyperoxia 
followed by MV—may be even more damaging than the either hyperoxia or VALI alone.  
In an in vitro model of VALI, Roan et al demonstrated that alveolar epithelial cells 
treated with hyperoxia and cyclic stretch developed significantly more damage than cells 
treated with either stimulus alone (Roan et al., 2012).  In a second study, Wilhelm et al 
reduced damage from cyclic stretch on hyperoxia treated cells by inhibiting rho-
associated protein kinase (ROCK) in these cells (Wilhelm, Roan, Ghosh, Pathasarathi, & 
Waters, 2014).  ROCK is involved in a molecular pathway that leads to the formation of 
stress fibers and promotes cellular contractility (Riento & Ridley, 2003).  It is possible 
that these also play a role in damage caused by over-distension of alveolar epithelial 
cells.   
 A key cytokine in lung injury, tumor necrosis factor- alpha (TNF-α), induces 
contractility in cells by activating ROCK as well as myosin light chain kinase (MLCK) 
(Flynn & Helfman, 2010).  Concentrations of TNF-α are elevated in the lungs of 
pneumonia and sepsis patients (Meduri et al., 1995), supporting the idea that, in ARDS 
patients, alveolar epithelial cells are exposed to TNF-α prior to MV.  Since the 
combination of hyperoxia and over-distention was shown to be worse than either stimulus 
alone, it is plausible that the combination of TNF-α exposure prior to mechanical 
ventilation will have a similar effect by causing worse injury to the alveolar epithelial 
cells.  As such, the hypothesis of this thesis is that alveolar epithelial cells exposed to 








Hypoxemia and the presence of pulmonary edema are common symptoms used to 
diagnose a patient with ARDS.  These symptoms must also occur within seven days of a 
known clinical insult or a new/worsening respiratory symptom (The ARDS Definition 
Task Force, 2012).  Known as the Berlin Definition, these three parameters were defined 
by the ARDS Definition Task Force in 2012 to better diagnose ARDS in patients.  
2.1.A Hypoxemia  
Patients with severe lung trauma are unable to adequately exchange gases 
(oxygen and carbon dioxide) with the atmosphere.  This results in the accumulation of 
CO2 in the blood and the inability to oxygenate the blood (hypoxemia).  When dissolved 
CO2 accumulates in the blood, the excess CO2 lowers the blood’s pH; this condition is 
known as respiratory acidosis (Nation Health Institute, 2014).  Hypoxemia is defined by 
low levels of oxygen in the blood (Mayo Clinic, 2013).  Oxygenation of the blood is 
measured by comparing the partial pressure of arterial oxygen (PAO2) to the fraction of 
inspired oxygen (FiO2).  This comparison is known as the PAO2/FiO2 ratio.  At 
atmospheric pressure with normal atmospheric air, the typical PAO2 is 80-100 mmHg.  
The FiO2 of atmospheric air is 0.21 because air is 21% oxygen.  This results in a healthy 
PAO2/FiO2 ratio of 380-475 mmHg.  Below this value, patients are considered 
hypoxemic.   
Hypoxemic patients are treated with supplemental oxygen (hyperoxia) which 
raises the FiO2. Higher concentrations of oxygen in the lungs increases oxygen diffusion 
into the blood.  Hypoxemia is one of the main identifiers used to diagnose ARDS.  The 
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Berlin Definition divides ARDS into three severities based on hypoxemia: mild 
(200mmHg < PaO2/FiO2 ≤ 300 mmHg), moderate (100 mmHg < PaO2/FiO2 ≤ 200 
mmHg), and severe (PaO2/FiO2 ≤ 100 mmHg) (The ARDS Definition Task Force, 2012).   
2.1.B Pulmonary Edema 
In addition to hypoxemia, ARDS diagnosis requires the presence of pulmonary 
edema.  Edema occurs when the rate of fluid movement into the lungs exceeds the lungs 
capacity to clear the fluid (Yang et al., 2010).  Edema is caused by three main factors:  
i) Dysfunction of sodium channels in the alveolar epithelial type II (AEII) cells; 
ii) Increased capillary pressure caused by cardiac dysfunction which forces fluid into 
the lungs from the capillaries; and,  
iii)  Barrier dysfunction in endothelial cells and alveolar epithelial cells which allows 
excess fluid to flow into the alveolar cavity from interstitial spaces. 
  When heart failure is the cause of edema it is called cardiogenic edema; this form 
of edema typically has low protein content. When edema is caused by alveolar barrier 
dysfunction, it is called either non-cardiogenic edema, pulmonary edema, or permeability 
edema. The resulting fluid in the alveoli is typically high in protein content which impairs 
the lungs ability to clear the fluid (Birukov, Zebda, & Birukova, Barrier Enhancing 
Signals in Pulmonary Edema, 2013). 
2.2 Alveolar Barrier Function 
In a cluster of alveoli, adjacent alveoli share structural walls.  The alveolar septum 
connects two adjacent alveoli.  As shown in Figure 1, the alveolar cavity is lined with a 
single layer of epithelial cells.  Capillaries weave between alveoli and are lined with a 
layer of endothelial cells. The basement membrane provides scaffolding for the alveolar 
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cells and is composed of elastin and collage (Hlastala & Berger, 2001).  Each of these 
structures contributes to the barrier function of the alveoli that allow the lung to function.  
However, the epithelial layer—and the tight junctions connecting cells—are critical to 
alveolar barrier function (Yang et al., 2010). 
Alveolar epithelial type I (AEI) cells are squamous in shape and they form a 
monolayer that lines the alveolar cavity (Figure 1).  They are connected to one another by 
multiple junctional proteins that regulate the flow of fluid and ions through the 
monolayer.  For example, gap junctions “form channels allowing neighboring cells to be 
interconnected” (Johnson & Koval, 2009). Also, the adherens junctions provide strong 
mechanical connections between cells (Lappi-Blanco et al., 2013).  Finally, tight 
junctions (TJs) regulate paracellular permeability and fluid flow between the basolateral 
and apical surfaces of the epithelial monolayer (Koval, 2013). TJs are highly integrated 
with the actin cytoskeleton.  Disruption of F-actin by cytochalasin D (cytoD: an actin 
depolymerizing agent) increases epithelial monolayer permeability in cultured cells 
(Rodgers & Fanning, 2011).   
 Alveolar epithelial type II (AEII) cells are cuboidal in shape and are located in the 
alveolar-septal junction (Figure 1).  AEII cells play an important role in wound repair by 
proliferating and migrating to injured areas.  They then take on an AEI-like phenotype to 
restore barrier function (Crosby & Waters, 2010).  In response to edema, AEII cells 
actively transport sodium ions to the basolateral side of the epithelial monolayer, driving 







Figure 1. Depiction of a normal (left) and injured (right) alveolus.  The healthy alveolus 
is lined with AEI cells while the injured alveolus has denuded cells, inflammation.  Used 
with permission (Matthay & Zemans, The Acute Respiratory Distress Syndrome: 




2.3 Pro-inflammatory Cytokines and Alveolar Barrier Dysfunction 
Cytokines are small signaling proteins produced by a wide range of cell types 
throughout the body (Dinarello, 2000).  Cytokines typically signal locally as opposed to 
hormones which can be transported throughout the body (Dinarello, 2000).  Cytokines 
are primarily associated with immune responses and are produced in response to cell 
stressors (Dinarello, 2000).  Three major families of cytokines are interleukins (IL), 
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interferons (IFN), and tumor necrosis factors (TNF); each family contains numerous 
unique cytokines with various effects on cells.  For example, TNF-α and IL-8 have a 
positive chemotaxic effect on neutrophils (Smart & Casale, 1994).  Both IL-1 and TNF-α 
upregulate endothelial adhesion molecules, which are essential to leukocyte adhesion and 
emigration into injured areas (Dinarello, 2000).  TNF-α has also been shown to aid in the 
removal of edema from alveoli by increasing sodium uptake in alveolar epithelial cells 
(Rezaigula et al., 1997).  In addition to these benefits, cytokines also have several 
deleterious effects on the lung alveoli. 
Many harmful cytokines also promote inflammation and are called pro-
inflammatory cytokines.  TNF-α is a notable pro-inflammatory cytokine and is known to 
both induce apoptosis and promote cell survival (Flynn & Helfman, 2010).  In ARDS 
patients, TNF-α is present in high concentrations in broncho-alveolar lavage fluid 
(Meduri et al., 1995).  TNF-α causes TJs to loosen their relatively impermeable barrier by 
downregulating the zonula occludens-1 (ZO-1) and occludin proteins in TJs (Petecchia et 
al., 2012).  In epithelial cells, TNF-α triggers F-actin reorganization and alteration of TJ 
structure (Capdaldo & Nursat, 2009).    
One mechanism by which TNF-α disrupts TJ function is through F-actin 
modulation. TNF-α activates myosin light chain kinase (MLCK) and Rho kinase; 
activation of these kinases phosphorylates myosin light chains (MLC).  Activation of 
MLC produces a contractile force in the cell (Flynn & Helfman, 2010), and this has been 
shown to increase epithelial cell permeability (Rodgers & Fanning, 2011). CytoD, ML-7 
and Y-27632 are mediators that reduce cell contractility.  CytoD promotes 
depolymerization of F-actin while ML-7 and Y-27632 selectively inhibit MLCK and Rho 
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kinase, respectively.   The use of ML-7 and Y-27632 have been shown to reduce 
epithelial barrier dysfunction (Guo et al., 2012; Schlegel, Meir, Spindler, Germer, & 
Waschke, 2010). 
2.4 Mechanical Ventilation 
Treatment of ARDS primarily consists of oxygen supplementation and MV 
(Matthay & Zemans, The Acute Respiratory Distress Syndrome: Pathogensis and 
Treatment, 2011).  As PAO2/FiO2 levels fall, high levels of oxygen are administered to 
improve oxygenation.  If PAO2/FiO2 levels continue to fall, a patient must be 
mechanically ventilated.  MV is used to assist or replace a patient’s spontaneous 
breathing.  During MV, a constant volume of air is pumped into the lungs through an 
endotracheal tube.  This is called positive pressure MV.  The volume of air used during 
MV is determined based on the patient’s predicted body weight (predicted from height 
and sex).  At rest, the typical tidal volume for an adult male is 7-8 mL of air per kg of 
predicted body weight (mL/kg) (ARDS Network, 2000).  Previous ARDS treatment 
employed tidal volumes of 10-15 mL/kg.  Now known as high tidal volume MV, the 
large volume of air was often required to achieve sufficient gas exchange in the 
pathologic lung (ARDS Network, 2000).  MV, especially with high tidal volumes, is 
capable of perpetuating existing lung injuries or even inducing new lung injury (ARDS 
Network, 2000).  Known as ventilator associated lung injury (VALI), this method of 
injury is a large obstacle for ARDS treatment.  Limiting VALI is the only proven method 
for reducing ARDS mortality rates (Plataki & Hubmayr, 2010).     
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2.5 Ventilator Associated Lung Injury 
The exact mechanisms of VALI are hard to elucidate because lung imaging is 
currently limited.  Real-time information of alveolar damage is impossible because of 
inherent limitations in imaging techniques (Plataki & Hubmayr, 2010).  Despite these 
limitations, many mechanisms of lung injury have been proposed and investigated.    
2.5.A Atelectrauma and Microbubble Propagation 
Atelectasis is the cyclic opening and closing of an alveolus.  Large interfacial 
forces and shear stresses are produced by the air-liquid interface when the alveolus 
collapses and reopens (Slutsy, 1999).  These forces can injure alveolar epithelial cells of 
the collapsed and adjacent alveoli (dos Santos & Slutsky, 2006).  In healthy alveoli, AEII 
cells produce surfactant to reduce surface tension within the alveolus, which prevents 
alveolar collapse.  The surfactant plays a protective role in the event of alveolar collapse; 
however, surfactant depletion is a common symptom following edema (Slutsky & 
Ranieri, 2013).  In animal models of atelectasis, healthy lungs treated with negative end-
expiratory pressure (to forcibly close the alveoli) did not experience injury, but even a 
mild surfactant dysfunction lead to severe injury (Bilek, Dee, & Gaver, 2003).   
Similarly, the propagation of microbubbles within the airways of the lungs can injure 
epithelial cells.  Atelectasis of edema-filled alveoli and airways produces these 
microbubbles.  Movement of microbubbles produces injurious air-liquid interface that 
damage epithelial cells (Ghadiali & Gaver, 2008). 
2.5.B Over-Distension and Cell Injury 
 During normal tidal breathing, it is estimated that the alveolar epithelial cells and 
basement membrane experience 4% linear distension (Fredberg & Kamm, 2006).  Lung 
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expansion from residual lung capacity (volume after passive exhalation) to total lung 
capacity can linearly distend epithelial cells an estimated 40% (Roan & Waters, What do 
we know about mechanical strain in lung alveoli?, 2011).  Cell damage can occur to cells 
during cyclically stretched at magnitudes over 17% linear distension (Tschumperlin & 
Margulies, 1998).  ARDS lungs are heterogeneously injured (i.e. some alveoli are injured 
while others remain healthy).  Injured and edema filled alveoli may be less compliant 
than healthy alveoli.  Because positive pressure MV prescribes a constant volume of air, 
healthy alveoli are potentially over inflated while pathologic alveoli receive little to no air 
(Waters, Roan, & Navajas, 2012).  Over inflation causes epithelial cells and tight 
junctions to be damaged by high tensile stresses (Plataki & Hubmayr, 2010).  This thesis 
further investigates over-distension by looking at cell damage and potential tearing.  
When tensile forces acting on alveolar epithelial cells exceed the strength of cellular 
structures and junctions, it is possible that the cells physically tear apart from one 
another.   
2.6 Prevention of VALI 
Preventing VALI through low tidal volume MV the only proven method for 
reducing the mortality rate of ARDS (Plataki & Hubmayr, 2010).  Low tidal volume MV 
uses positive pressure ventilation with volumes ranging from 4-7 ml/kg.   In a clinical 
trial, the ARDS Clinical Network demonstrated that low tidal volumes combined with 
positive end-expiratory pressure was able to reduce mortality rates in ARDS (ARDS 
Network, 2000).   
Building upon the ARDSnet findings, other methods for attenuating ARDS have 
been extensively investigated.  One such method is prone positioning in which the patient 
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lies face down during MV.  The proposed benefits of prone positioning in ARDS include: 
optimized chest mechanics and enhanced drainage of tracheobronchial secretions (Beitler 
et al., 2014).  Although Taccone et al. did not show increased survival in their study, a 
meta-analysis by Beitler et al. showed that prone positioning combined with low tidal 
volume reduces the risk of mortality in ARDS patients (Beitler et al., 2014; Taccone et 
al., 2009).   
 Recruitment maneuvers are another method used to treat lungs in ARDS patients.  
Recruitment maneuvers are ventilator strategies used to reopen collapsed alveoli.  By 
reopening alveoli, recruitment maneuvers increase the surface area available for gas 
exchange.  In ARDS patients, recruitment maneuvers have been shown to briefly improve 
oxygenation and lung compliance (Keenan, Forment, & Marini, 2014).  A common 
recruitment maneuver is sustained inflation.  In this ventilation strategy, continuous 
positive airway pressure (CPAP) is abruptly raised over a short time in an effort to reopen 
previously collapsed alveoli.   
 Aside from ventilator based strategies for reducing VALI, pharmaceutical 
interventions also exist.  Keratinocyte growth factor (KGF) has pleiotropic effects on 
alveolar epithelial cells that include increased proliferation, migration, fluid clearance and 
wound repair (LaFemina et al., 2010; Ware & Matthay, 2002).  LaFemina et al. found 
that pretreatment with KGF increased barrier function (TER) in isolated AEII cells 
(LaFemina et al., 2010). Welsh et al even demonstrated the protective effect of KGF 
against VALI in an ex vivo rat model (Welsh, Summer, Dobard, Nelson, & Mason, 2000).  
Because KGF can prevent barrier dysfunction in alveolar epithelial cells and reduce 
VALI, KGF may also be able to reduce damage due to over-distension.    
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 Mouse lung epithelial cells (MLE-12) [American Type Culture Collection 
(ATCC), Manassas, VA]. MLE-12 culture media containing Dubelco’s Modified Eagle 
Medium (DMEM) [Mediatech, (Manassas, VA)], 10% heat inactivated fetal bovine 
serum (FBS) [Life Technologies (Carlsbad, CA)], HEPES, 4mM L-glutamine [Life 
Technologies (Carlsbad, CA)], and 1% penicillin/streptomycin [Life Technologies 
(Carlsbad, CA)]. Tumor necrosis factor- alpha [TNF-α (Peprotech)].  Keratinocyte 
growth factor (KGF) [Peprotech(Rocky Hill, New Jersey)]. FlexCell Tension System. 
Bioflex Collagen I-coated, culture plates, ML-7 [Sigma Aldrich (St. Louis, MO)], Y-
27632 [Sigma Aldrich (St. Louis, MO)]. 
3.2 Methods 
3.2.A Cell Culture 
MLE-12 cells were cultured with MLE-12 cell culture media with 10% FBS.  All 
cells were incubated with 5% CO2 – 95% atmospheric air at 37 °C. Flasks were passaged 
at 85-95% confluency.  All experiments were done between a passage number of 10-30.  
3.2.B Over-distention experiments with FlexCell© Tension System  
FlexCell culture plates are 6-well plates with a flexible, silicon rubber culture 
surface.  The silicon is coated with collagen I to facilitate cell adhesion.  The plates were 




 and became confluent on the second day.  At time zero, the 
culture media was removed and fresh media added to control wells. TNF-α dissolved in 
MLE-12 culture media at concentrations of 5 or 50 ng/mL was added to selected wells.  
After 6 hours of exposure to TNF-α, FlexCell plates designated for stretch conditions 
13 
 
were moved to an incubator containing the FlexCell tension system.  FlexCell plates 
designated for static conditions were left in the original incubator.  In one experiment, the 
media was replaced before cyclic stretch.  In subsequent experiments, the TNF-α 
containing media remained in wells during cyclic stretch. 
Cytoskeleton mediating reagents (30µM ML-7, 20µM Y-27632) were added to 
media 30 minutes before TNF-α.  0.1µM CytoD and 100ng/mL KGF were added the last 
30 minutes of TNF-α treatment (e.g., 30 minutes before cyclic stretch). 
The FlexCell tension system applies a mechanical load to the experimental plates.  
By pulling a vacuum beneath the FlexCell culture plate, the flexible bottoms of the wells 
stretched to a designated magnitude.  Twenty percent stretch magnitudes were applied at 
15 cycles per minute (cpm) for durations ranging from 30 minutes to 4 hours.  After the 
stretch regimen was complete, both control and experimental plates were fixed with a 
solution of 4% paraformaldehyde in 1% PBS.  
3.2.C Imaging Damaged Monolayers of AE Cells 
After stretch application, the fixed cells were imaged using an EVOS digital 
microscope (AMG, Mill Creek, WA) at 20X magnification.  Images were taken at a 
minimum of 10 random locations across the membrane to get adequate sampling of the 
entire well.  Edges of the membrane were not imaged because stretch magnitude is 
reduced closer to the well boundaries. 
3.2.D Processing and Analyses of Images 
Images were analyzed using Adobe Photoshop (San Jose, CA) and Matlab 
(Natick, MA).  Using Photoshop, the cell free area was “masked.”  This means that the 
cell free area was manually selected and highlighted black as shown in Figure 2.  Using a 
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Matlab code (Appendix A), the percentage of black pixels to non-black pixels was 
calculated. This percentage is reported as the “cell-free area.”  Multiple images were 
taken of each well.  Within each well, the cell-free area of each image was averaged to 





Figure 2. (A) An original image taken of a FlexCell membrane after a stretch experiment.  
(B) Using Adobe Photoshop, cell free areas were highlighted in black 
 
 
3.2.E Near Real Time Imaging of AE Monolayer Over-Distention  
The cell actuator shown in Figure 3A is a custom made device that applies multi 
axial stretch to a flexible membrane.  The membranes used on the cell actuator are 
produced from sheets of FlexCell collagen I coated membrane material (Figure 3B).  A 
customized punch was used to cut the desired shape from the FlexCell sheet.  A wall 




media.  The membranes were placed on the actuator as shown in Figure 4.  The actuator 
was manipulated by hand to apply a planar stretch to the membrane.  In the current work, 
membranes were stretched incrementally.  Images were taken at the relaxed state, 
maximal stretched state, and approximately midway between the relaxed and maximal 
stretch states.  Bright field images were recorded with the EVOS digital microscope at 
20X magnification.   
 
 
   
Figure 3. (A) Cell actuator.  (B) Custom membrane for the cell actuator. The barrier on 
the membrane allows for the use of cell culture media.  The tabs on the membrane are 
held in place with the clamps on the actuator. The movement of the actuator is controlled 










Figure 4. Cell actuator with membrane installed. 
 
 
3.2.F Statistical Analysis 
Using SigmaPlot (San Jose, CA), two-way ANOVA with pairwise comparison 
and Holm-Sidak posthoc test was used for all cell over-distension data. Statistical results 
are shown in Appendix A.
 
 
Chapter 4: Results 
 
 
The lung parenchyma experiences continuous, cyclic stretching.  Under normal 
conditions, lung tissue is adapted for cyclic stretching.  Epithelial cells, endothelial cells 
and the basement membrane stretch and relax with each respiratory cycle and do not 
experience damage as a result of normal mechanical loading.  However, we postulate that 
pathologic conditions present in ARDS patients, primes the lungs to be more sensitive to 
mechanical loading.  In the case of mechanical ventilation (MV), the combination of 
pathologic lungs and larger than normal stretch magnitudes leads to more lung injury and 
possibly contribute to the high mortality rates seen in ARDS.   
4.1 Synergistic Effect of TNF-α and Cyclic Stretch 
To show the synergistic damaging effect of TNF-α and mechanical stretch, MLE-
12 cells were incubated with TNF-α for 6 hours immediately followed by cyclic stretch 
(20% stretch, 15 cpm).  Monolayers that were not stretched (static) and did not receive 
TNF-α treatment remained completely confluent. Monolayers treated with either TNF-α 
or stretch showed very low amounts of cell damage.  However, monolayers treated with 
stretch and TNF-α clearly exhibit cell-free areas (Figure 5).   
Analyses of images showed that monolayers that received only stretch or only 
TNF-α (with wash) had 0.92(±1.2) and 2.5(±1.5)% cell-free area, respectively (Figure 6). 
The combination of these two conditions resulted in 18.7 (±7.2)% cell-free area, which is 
over 7 times more than either stimulus alone.  Monolayers in which TNF-α was not 
removed before cyclic stretch had an even greater increase in cell-free area.  These results 
show that TNF-α combined with cyclic stretch cause synergistic damage to an epithelial 






Figure 5. Typical images of MLE-12 monolayers treated with 50 ng/mL of TNF-α for 6 
hours followed by 4 hours of cyclic stretch (20% stretch, 15 cpm).  The combination of 









Figure 6. The combination of TNF-α treatment and cyclic stretch increased cell-free area 
compared to either stimulus by itself.  Confluent cells were stretched with 20% strain at 
15 cpm for 30 minutes.  Three cell seeding events; N of 9. STD shown. * Denotes 
difference between static and stretch within the same TNF-α treatment.   Bars denote 
differences between conditions that share stretch stimulus, p=0.05. 
 
 
Additional experiments were performed to better describe the timeline of damage 
in this model for alveolar epithelial cell damage.  The aim was to understand how early 
the damage to the monolayer occurred during over-distension. The TNF-α conditions 
were maintained from the previous experiments, i.e., 6 hours, 50 ng/mL.  Compared to 
static cells, cyclic stretch for only 30 minutes increased cell free area by over 18% 
(Figure 7).  In these experiments, the cells were washed before stretch application. 
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Figure 7. Cyclic stretch increases cell-free area after only 30 minutes. MLE12 cells were 
grown to confluence, treated with 50ng/mL of TNF-α for 6 hours, and stretched with 
20% strain at 15cpm for 0.5, 1, and 2 hours.  Two cell seeding events; N of 5.  STD 
shown, * Denotes difference between static and stretch within the same TNF-α treatment.  
Lines denote differences between conditions that share stretch stimulus P<0.05. 
 
 
4.2 Application of a Single Stretch on TNF-α Treated Epithelial Cells 
To learn when monolayer damage begins, experiments were performed on the cell 
actuator.   Using the cell actuator developed by Dr. Roan’s lab, a single stretch was 
applied to TNF-α treated cells.  The maximum magnitude of this stretch is estimated to 
be 20% applied at a rate of 0.05 s
-1
.  The actuator allows for near-real time imaging of a 
monolayer of cells as they are being stretched.  Stretch is applied incrementally to the 
membrane and the membrane can be held in the stretched position.  Images were taken 
while the stretch was held.  Cells treated by TNF-α appeared to tear apart during the first 
application of stretch (Figure 8).  Healthy monolayers were able to withstand stretch by 
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image is the same field and images were taken at subsequent stretch magnitudes.  The red 




Figure 8. Near real-time imaging of TNF-α treated cells shows cell tearing with a single 
application of stretch.  Each image is of the same field of cells.  The arrows indicate cells 
that tear apart as stretch is applied.  (A) Not stretched.  (B) Approximately 10% linear 
distension. (C) Approximately 20% linear distension. 
 
 
4.3 Stretch Induced Monolayer Damage Is Dependent on TNF-α Dosage 
To show the dependence of monolayer damage on TNF-α dosage, a TNF-α 
concentration of 5 ng/mL was added to the experimental protocol while all other 
experimental parameters were maintained similar to previous experiments. Qualitative 
images clearly show the reduction in cell-free area with the lower dose of TNF-α (Figure 
22 
 
9). Wells with 5ng/mL of TNF-α had 9% less cell-free area compared to wells treated 
with 50ng/mL (Figure 10).  However, even the monolayers treated with 5 ng/mL of TNF-
α still show a 4% increase in cell-free area over stretched wells without TNF-α treatment.  





Figure 9: Stretch induced damage in AE monolayers is dependent on TNF-a dose. Cell-
free area without stretch is independent of TNF-α dose. Cyclically stretched wells, 






Figure 10: Cell free area resulting from cyclic stretch is dependent on TNF-α 
concentrations.  TNF-α doses do not significantly increase cell-free area in static wells.  
Cyclically stretched wells, however, show significant increases in cell-free area at each 
dose. Two cell seeding events, N of 4, STD shown. * Denotes difference between static 
and stretch within the same TNF-α treatment.   Lines denote differences between 




4.4 Prevention  
4.4.1 F-Actin Modulation and Monolayer Damage 
To determine the role of TNF-α induced contractility plays in this model of over-
distension of alveolar epithelial cells, cytoskeletal mediators were used to inhibit 
contraction of the cytoskeleton.  Epithelial monolayers were treated with cytoD, ML-7, or 
Y-27632 followed by TNF-α, which all aimed at reducing the contraction in the cells.  
CytoD was added the last 30 minutes of TNF-α treatment at a concentration of 0.1 µM.  
This concentration was chosen because it promotes depolymerization of F-actin without 
disrupting the epithelial monolayer.  In the studies using ML-7 and Y-27632, cells were 
























concentrations of ML-7 and Y-27632 used were 30 µM and 20 µM respectively.  The 
concentration of ML-7 was obtained from studies showing that ML-7 reduced the 
formation of F-actin stress fibers in epithelial cells treated with cyclic stretch.  The 
concentration of Y-27632 was used by Wilhelm et al to reduce damage caused by over-
distension to hyperoxia treated cells.  No apparent improvement in cell-free area was 
observed as shown in representative bright field images in Figures 11 and 12. Although 
this experiment was only performed once, experience with the protocol led me to believe 
that the contractility mediators were not effective in reducing damage due to over-
distension in TNF-α treated cells.  Because the aim was to reduce or eliminate the 





Figure 11. Treatment with cytoD increases cell free area in both control and TNF-α 





Figure 12. All images are of stretched conditions. Modulation of f-actin with ML-7 and 
Y-27632 did not reduce cell free area caused by TNF-α and cyclic stretch.  Typical 
images of cell free area shown. 
 
 
4.4.2  Keratinocyte Growth Factor 
KGF has shown promising results by reducing epithelial barrier dysfunction and 
reducing VALI in an ex vivo rat model (LaFemina et al., 2010; Welsh et al., 2000).  A 30- 
minute application of KGF immediately before cyclic stretch was unable to reduce the 







previous experiments, epithelial monolayers were treated with 5 and 50ng/mL TNF-α for 
6 hrs.  After 5 hrs and 30 min of TNF-α treatment, KGF was added to the wells for a final 
concentration of 100 ng of KGF per mL of media. After 30 min with KGF, wells were 
cyclically stretched.  The analyses of images showed that the TNF-a and stretch still 
caused 11% cell free area and the KGF treated cells after TNF-a and stretch still 






Figure 13. 6 hours of TNF-α treatment.  30 minutes of KGF treatment 30 minutes prior to 
















Figure 14. Thirty minutes of treatment with 100ng/mL of KGF immediately before cyclic 
stretch did not reduce cell-free area caused by TNF-α treatment and cyclic stretch.  20% 
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Chapter 5: Discussion 
 
 
Lungs are susceptible to numerous types of infections and injuries; and, many of 
these can lead to ARDS.  Decreased alveolar barrier function and increased amounts of 
pro-inflammatory cytokines and pulmonary edema in the lungs are characteristic 
symptoms.  The resulting hypoxemia is treated with MV, but MV can further perpetuate 
ARDS symptoms.  High tidal volume MV can even cause de novo inflammation and 
cytokine production in otherwise healthy lungs (Pinheiro de Oliveira, Hetzel, dos Anjos 
Silva, Dallegrave, & Friedman, 2010).  Understanding why lungs of ARDS patients are 
more susceptible to VALI and by which mechanisms they are injured are key to 
improving survival rates of ARDS patients.  By treating cultured, mouse lung epithelial 
(MLE-12) cells with TNF-α and applying cyclic stretch with the FlexCell Tension 
System, this work shows the effect pro-inflammatory cytokines can have in the formation 
of alveolar epithelial injury.  
Precise knowledge of alveolar epithelial injury is difficult to obtain because 
modern imaging technology is unable to image within an alveolus.  Nevertheless, several 
mechanisms by which alveolar epithelial cells may be injured have been proposed and 
studied.  In the case of over-distension, high tensile loading damages epithelial cells and 
their TJ.  During over-distension, it is possible that cells are physically injured.  Figure 8 
shows the stepwise formation of a tear forming in a monolayer of TNF-α treated, MLE-
12 cells as they are stretched.  If this were to occur in an alveolus, permeability would no 
longer be a function of TJ structure and integrity; the cell-sized hole in the monolayer 
would allow the influx of edema. 
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The damage in the monolayer of cells highlights important limitations in current 
ARDS research.  First of all, many studies attempting to improve epithelial permeability 
rely on transepithelial electrical resistance (TER) as a measure of monolayer function.  
However, these measurements are done on static cells, whereas alveolar epithelial cells 
are constantly cyclically stretched (with high magnitudes during MV).  If cells are injured 
during over distension, simply improving TJ function cannot prevent edema.  Second, 
even though this research uses the FlexCell device to allow for the inherent mechanical 
stimulus in alveoli, the stretch is released before the images are taken.  This means that 
the membranes in the FlexCell plates are in the relaxed position while on the microscope.  
In the present study, images recorded on relaxed membranes could lead to 
underestimation of the cell-free area.  Continued research with the cell actuator will 
compensate for the limitations of the FlexCell system.   
In addition to showing cell tearing occurring in MLE-12 cells, this study shows 
that damage begins remarkably early in the cyclic stretching process.  Cells treated with 
TNF-α show tearing with one application of stretch and significant increases in cell-free 
area occur as early as 30 min.  These cells were exposed to TNF-α for 6 hours.  Patients 
who develop ARDS from infections do so over days.  Meduri et al showed that in ARDS 
patients with pneumonia or sepsis, the BAL fluid has TNF-α concentrations of 50 ng/mL 
(Meduri et al., 1995).  Prolonged exposure to high levels of TNF-α likely makes alveolar 
epithelial cells extremely susceptible to physical damage.  As a result, a truly “protective” 
ventilator strategy may not be possible without first addressing the damage TNF-α and 
other pro-inflammatory cytokines have done to the epithelial cells.   
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Each experiment, regardless of TNF-α concentrations or mechanical stretch 
durations, showed an increase in cell-free area in monolayers receiving both TNF-α and 
mechanical stretch.  The data in Figure 6 shows that removing TNF-α before mechanical 
stretch reduces the resulting cell-free area.  The data in Figure 9 shows that reducing the 
concentration of TNF-α also shows a reduction in the cell-free area after mechanical 
stretch.  The amount of TNF-α before cyclic stretch and the presence of TNF-α during 
cyclic stretch both affected the magnitude of cell-free area.  This suggests that blocking 
TNF-α production or its uptake by epithelial cells could reduce VALI.  Using a high tidal 
volume model of VALI in rats, Guery et al showed that lung permeability was reduced by 
using a TNF-α neutralizing agent (Guery et al., 2003).  However, using an extracorporeal 
circulation model to induce acute lung injury in rats and blocking TNF-α binding to its 
receptors, Zhoa et al was not able to show an increase in lung function (Zhao et al., 
2014).  Inhibiting TNF-α may still have potential in the treatment of ARDS. However, 
elucidating the targets and methods of inhibition require more research before TNF-α is a 
viable solution to ARDS.   
Finally, TNF-α induced contractility has been shown to increase TJ permeability.  
Some commonly used mediators to reduce cell contractility are ML-7, Y-27632 and 
cytoD.  Although quantitative studies were not carried out, the use of these mediators did 
not appear to reduce damage due to over-distension.  This could suggest that F-actin 
contractility is not a main contributor in cell tearing as seen these experiments.  
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Chapter 6: Limitations 
 
 
 The primary limitations to this work include: 
 MLE-12 cells are cultured in static conditions.  The actual environment of the lung is 
dynamic, and cells proliferate, migrate and function while experiencing low amounts of 
cyclic stretch.  It is possible that the low stretch magnitudes alter the  effect of high tidal 
volume MV  
 Cells are affected by the substrate on which they are grown.  Whereas the FlexCell 
membranes are much softer than plastic or glass, they are still orders of magnitude harder 
than the basement membrane on which AEI cells grow.  On harder substrates, the 
inherent mechanical properties of the cells are possibly very different.   
 TNF-α is known to induce apoptosis and necrosis in epithelial cells.  Increased apoptosis 




Chapter 7: Conclusions 
 
 
The pro-inflammatory cytokine TNF-α has a multitude of effects on alveolar 
epithelial cells.  In ARDS patients, many of these effects contribute to alveolar epithelial 
cells susceptibility to VALI.  In vitro this translates to increased cell-free area when 
MLE-12 monolayers are cyclically stretched in FlexCell membranes.  The conclusions to 
this thesis are listed here:  
 When alveolar epithelial cells were treated with TNF-α and then mechanically stretched, 
the resulting damage was greater than damage caused by either stimulus alone.   
 The monolayer damage due to stretch was dependent on TNF-α concentration.   
 The damage to TNF-α treated monolayers began as early as the first stretch. 
 After 30 minutes of stretch, TNF-α treated cells showed significant increases in cell-free 
area.   
 Application of 100 ng/mL of KGF to monolayers 30 minutes prior to cyclic stretch was 




Chapter 8: Future Work 
 
 
There are multiple potential avenues in which this work can be carried forward. 
1. These experiments need to be confirmed with the use of primary alveolar epithelial cells.   
2. Role of KGF in preventing injury: Time course and dose studies may elucidate methods 
for reducing cell injury.   
3. Quantitative research using the cell actuator:   Pinpointing thresholds at which cell 
tearing occurs will greatly contribute to our knowledge of VALI in ARDS patients.   
4. The use of fluorescence imaging with live cells (i.e., F-actin, tight junctions) as they are 
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A: SigmaPlot Reports 
 
Report for Figure 6: 
 
Two Way Analysis of Variance Tuesday, August 19, 2014, 10:11:42 AM 
 




Dependent Variable: Col 3  
 
Normality Test: Failed (P < 0.050) 
 
Equal Variance Test: Failed (P < 0.050) 
 
Source of Variation  DF   SS   MS    F    P   
Col 1 1 1624.669 1624.669 88.266 <0.001  
Col 2 2 2455.488 1227.744 66.702 <0.001  
Col 1 x Col 2 2 779.196 389.598 21.166 <0.001  
Residual 30 552.196 18.407    
Total 35 5411.549 154.616    
 
 
Main effects cannot be properly interpreted if significant interaction is determined. This is because the size 
of a factor's effect depends upon the level of the other factor. 
 
The effect of different levels of Col 1 depends on what level of Col 2 is present.  There is a statistically 
significant interaction between Col 1 and Col 2.  (P = <0.001) 
 
Power of performed test with alpha = 0.0500:  for Col 1 : 1.000 
Power of performed test with alpha = 0.0500:  for Col 2 : 1.000 
Power of performed test with alpha = 0.0500:  for Col 1 x Col 2 : 1.000 
 
Least square means for Col 1 :  
Group Mean  
Static 3.872  
Stretch 17.307  
Std Err of LS Mean = 1.011 
 
Least square means for Col 2 :  
Group Mean  
0 ng 0.472  
50 ng wash 10.596  
50 ng no wash 20.702  
Std Err of LS Mean = 1.238 
 
Least square means for Col 1 x Col 2 :  
Group Mean  
Static x 0 ng 0.0161  
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Static x 50 ng wash 2.494  
Static x 50 ng no wash 9.105  
Stretch x 0 ng 0.927  
Stretch x 50 ng wash 18.697  
Stretch x 50 ng no wash 32.298  
Std Err of LS Mean = 1.752 
 
 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
 
Comparisons for factor: Col 2 within Static 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
50 ng no wash vs. 0 ng 9.089 3.669 <0.001 0.017 Yes  
50 ng no wash vs. 50 ng wash 6.611 2.669 0.012 0.025 Yes  
50 ng wash vs. 0 ng 2.478 1.000 0.325 0.050 No  
 
 
Comparisons for factor: Col 2 within Stretch 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
50 ng no wash vs. 0 ng 31.371 12.665 <0.001 0.017 Yes  
50 ng wash vs. 0 ng 17.770 7.174 <0.001 0.025 Yes  
50 ng no wash vs. 50 ng wash 13.601 5.491 <0.001 0.050 Yes  
 
 
Comparisons for factor: Col 1 within 0 ng 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
Stretch vs. Static 0.911 0.368 0.716 0.050 No  
 
 
Comparisons for factor: Col 1 within 50 ng wash 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
Stretch vs. Static 16.203 6.541 <0.001 0.050 Yes  
 
 
Comparisons for factor: Col 1 within 50 ng no wash 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  





Report for Figure 7 
 
Two Way Analysis of Variance Tuesday, August 19, 2014, 10:18:48 AM 
 




Dependent Variable: Col 3  
 
Normality Test: Failed (P < 0.050) 
 




Source of Variation  DF   SS   MS    F    P   
Col 1 3 1566.919 522.306 6.729 0.001  
Col 2 1 2823.742 2823.742 36.378 <0.001  
Col 1 x Col 2 3 761.769 253.923 3.271 0.034  
Residual 32 2483.912 77.622    
Total 39 7636.343 195.804    
 
 
Main effects cannot be properly interpreted if significant interaction is determined. This is because the size 
of a factor's effect depends upon the level of the other factor. 
 
The effect of different levels of Col 1 depends on what level of Col 2 is present.  There is a statistically 
significant interaction between Col 1 and Col 2.  (P = 0.034) 
 
Power of performed test with alpha = 0.0500:  for Col 1 : 0.929 
Power of performed test with alpha = 0.0500:  for Col 2 : 1.000 
Power of performed test with alpha = 0.0500:  for Col 1 x Col 2 : 0.514 
 
Least square means for Col 1 :  
Group Mean  
Static 1.494  
30 min CS 12.286  
1 hour CS 14.371  
2 hour CS 18.412  
Std Err of LS Mean = 2.786 
 
Least square means for Col 2 :  
Group Mean  
0 ng/mL TNF 3.239  
50 ng/mL TNF 20.043  
Std Err of LS Mean = 1.970 
 
Least square means for Col 1 x Col 2 :  
Group Mean  
Static x 0 ng/mL TNF 0.135  
Static x 50 ng/mL TNF 2.852  
30 min CS x 0 ng/mL TNF 3.363  
30 min CS x 50 ng/mL TNF 21.209  
1 hour CS x 0 ng/mL TNF 4.292  
1 hour CS x 50 ng/mL TNF 24.450  
2 hour CS x 0 ng/mL TNF 5.165  
2 hour CS x 50 ng/mL TNF 31.660  
Std Err of LS Mean = 3.940 
 
 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
 
Comparisons for factor: Col 2 within Static 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
50 ng/mL TNF vs. 0 ng/mL TNF 2.717 0.488 0.629 0.050 No  
 
 
Comparisons for factor: Col 2 within 30 min CS 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
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50 ng/mL TNF vs. 0 ng/mL TNF 17.846 3.203 0.003 0.050 Yes  
 
 
Comparisons for factor: Col 2 within 1 hour CS 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
50 ng/mL TNF vs. 0 ng/mL TNF 20.158 3.618 0.001 0.050 Yes  
 
 
Comparisons for factor: Col 2 within 2 hour CS 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
50 ng/mL TNF vs. 0 ng/mL TNF 26.495 4.755 <0.001 0.050 Yes  
 
 
Comparisons for factor: Col 1 within 0 ng/mL TNF 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
2 hour CS vs. Static 5.030 0.903 0.373 0.009 No  
1 hour CS vs. Static 4.157 0.746 0.461 0.010 No  
30 min CS vs. Static 3.227 0.579 0.567 0.013 No  
2 hour CS vs. 30 min CS 1.802 0.323 0.748 0.017 No  
1 hour CS vs. 30 min CS 0.929 0.167 0.869 0.025 No  
2 hour CS vs. 1 hour CS 0.873 0.157 0.877 0.050 No  
 
 
Comparisons for factor: Col 1 within 50 ng/mL TNF 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
2 hour CS vs. Static 28.808 5.170 <0.001 0.009 Yes  
1 hour CS vs. Static 21.598 3.876 <0.001 0.010 Yes  
30 min CS vs. Static 18.357 3.294 0.002 0.013 Yes  
2 hour CS vs. 30 min CS 10.452 1.876 0.070 0.017 No  
2 hour CS vs. 1 hour CS 7.210 1.294 0.205 0.025 No  
1 hour CS vs. 30 min CS 3.242 0.582 0.565 0.050 No  
 
Report for Figure 10 
 
 
Two Way Analysis of Variance Tuesday, August 19, 2014, 10:21:35 AM 
 
Data source: Data 1 in Notebook3 
 
General Linear Model 
 
Dependent Variable: Col 3  
 
Normality Test: Failed (P < 0.050) 
 
Equal Variance Test: Passed (P = 0.069) 
 
Source of Variation  DF   SS   MS    F    P   
Col 1 1 257.017 257.017 56.850 <0.001  
Col 2 2 213.490 106.745 23.611 <0.001  
Col 1 x Col 2 2 121.953 60.977 13.487 <0.001  
Residual 17 76.857 4.521    





Main effects cannot be properly interpreted if significant interaction is determined. This is because the size 
of a factor's effect depends upon the level of the other factor. 
 
The effect of different levels of Col 1 depends on what level of Col 2 is present.  There is a statistically 
significant interaction between Col 1 and Col 2.  (P = <0.001) 
 
Power of performed test with alpha = 0.0500:  for Col 1 : 1.000 
Power of performed test with alpha = 0.0500:  for Col 2 : 1.000 
Power of performed test with alpha = 0.0500:  for Col 1 x Col 2 : 0.992 
 
Least square means for Col 1 :  
Group Mean SEM  
Static 0.658 0.647 
Stretch 7.382 0.614 
 
 
Least square means for Col 2 :  
Group Mean SEM  
0 ng/mL TNF 0.984 0.812  
5 ng/mL TNF 2.869 0.752  
50 ng/mL TNF 8.207 0.752  
 
 
Least square means for Col 1 x Col 2 :  
Group Mean SEM  
Static x 0 ng/mL TNF 0.112 1.228  
Static x 5 ng/mL TNF 0.116 1.063  
Static x 50 ng/mL TNF 1.746 1.063  
Stretch x 0 ng/mL TNF 1.856 1.063  
Stretch x 5 ng/mL TNF 5.623 1.063  




All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
 
Comparisons for factor: Col 2 within Static 
Comparison Diff of Means t Unadjusted P Critical Level  
50 ng/mL TNF vs. 5 ng/mL TNF 1.630 1.084 0.294 0.017  
50 ng/mL TNF vs. 0 ng/mL TNF 1.634 1.006 0.329 0.025  
5 ng/mL TNF vs. 0 ng/mL TNF 0.00404 0.00249 0.998 0.050  
 
Comparison Significant?  
50 ng/mL TNF vs. 5 ng/mL TNF No  
50 ng/mL TNF vs. 0 ng/mL TNF No  
5 ng/mL TNF vs. 0 ng/mL TNF No  
 
 
Comparisons for factor: Col 2 within Stretch 
Comparison Diff of Means t Unadjusted P Critical Level  
50 ng/mL TNF vs. 0 ng/mL TNF 12.811 8.521 <0.001 0.017  
50 ng/mL TNF vs. 5 ng/mL TNF 9.045 6.016 <0.001 0.025  
5 ng/mL TNF vs. 0 ng/mL TNF 3.766 2.505 0.023 0.050  
 
Comparison Significant?  
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50 ng/mL TNF vs. 0 ng/mL TNF Yes  
50 ng/mL TNF vs. 5 ng/mL TNF Yes  
5 ng/mL TNF vs. 0 ng/mL TNF Yes  
 
 
Comparisons for factor: Col 1 within 0 ng/mL TNF 
Comparison Diff of Means t Unadjusted P Critical Level  
Stretch vs. Static 1.744 1.074 0.298 0.050  
 
Comparison Significant?  
Stretch vs. Static No  
 
 
Comparisons for factor: Col 1 within 5 ng/mL TNF 
Comparison Diff of Means t Unadjusted P Critical Level  
Stretch vs. Static 5.506 3.662 0.002 0.050  
 
Comparison Significant?  
Stretch vs. Static Yes  
 
 
Comparisons for factor: Col 1 within 50 ng/mL TNF 
Comparison Diff of Means t Unadjusted P Critical Level  
Stretch vs. Static 12.922 8.595 <0.001 0.050  
 
Comparison Significant?  











dirName  = 'Name of the directory '; 
dirFiles = dir([dirName '*m.jpg']); 
numFiles = length(dirFiles); 
  
for ii=1:1:numFiles 
    cc  =  ceil(ii/5); 
    ccc =  ii - (cc-1)*5; 
     
    pic = imread([dirName '/' dirFiles(ii).name]); 
    data1 = im2bw(pic,0.1); 
    mn    = prod(size(data1)); 
  
     
    filledArea = mn - length(nonzeros(data1)); 
     
    ratio(cc,ccc) = 100* ([filledArea] / mn)  -  0.2; 
     
    ratioLinear(ii) = 100* ([filledArea] / mn)  -  0.2; 
     
     
    figure(1) 
    imagesc(data1); 
    title(num2str(ratio(cc,ccc))) 
     
     
end 
%% 
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